A carregar...
iRGD-modified lipid–polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability
Isoliquiritigenin (ISL), a natural anti-breast cancer dietary compound, has poor delivery characteristics and low bioavailability. In order to promote the therapeutic outcome of ISL, a tumor-targeting lipid–polymer hybrid nanoparticle (NP) system modified by tumor-homing iRGD peptides has been devel...
Na minha lista:
Publicado no: | Int J Nanomedicine |
---|---|
Main Authors: | , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5459978/ https://ncbi.nlm.nih.gov/pubmed/28615942 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S134148 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|